-+ 0.00%
-+ 0.00%
-+ 0.00%

Kymera Therapeutics files initial beneficial ownership statement for Chief Medical Officer Terence Rooney

PUBT·07/27/2026 22:26:02
Listen to the news
Kymera Therapeutics files initial beneficial ownership statement for Chief Medical Officer Terence Rooney
  • Kymera Therapeutics named Terence Rooney as chief medical officer in a Form 3 filing dated July 27, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-318404), on July 27, 2026, and is solely responsible for the information contained therein.